Novo Nordisk reported DKK10.91 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 10.91 5.86 6.53 May/06
FY2025Q4 Dec/2025 6.04 5.89 6.34 Feb/04
FY2025Q3 Sep/2025 4.50 5.52 6.12 Sep/26
FY2025Q2 Jun/2025 5.96 6.00 4.49 Aug/06
FY2025Q1 Mar/2025 6.53 6.35 5.68 May/07




Eps Change Date
Bausch Health Companies USD 0.78 0.3 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Novartis USD 1.99 0.04 Mar/2026
Novo Nordisk DKK 10.91 4.87 Mar/2026
Novo Nordisk DKK 1.02 0.01 Dec/2025
Pacira USD 0.6 0.54 Mar/2026
Sanofi EUR 1.88 0.35 Mar/2026
Supernus Pharmaceuticals USD 0.6 0.67 Mar/2026